Production of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale

Through these BioMaP-Consortium awards, ASPR IBMSC is partnering with the awardees listed below to develop a biological design-build-test cycle for the production of small molecule drug substances at commercial scale. This supports ASPR IBMSC’s broader long-term goal of developing and commercializing infrastructure that will be accessible to a broad community of Users for the purpose of producing drug substances, creating a new manufacturing paradigm that can be competitive in the global market and to onshore drug production.

Award ceilings and periods of performance reflect information at the time of award and may include unauthorized or unexercised options.